Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-05-10-Speech-4-314-625"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20120510.69.4-314-625"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
"In relation to the discharge of the budget of the European Medicines Agency, I share the points that have been made about the previous administration. At the same time, I would also like to underline that in a few short months, the body’s new management has taken important decisions for the healthy and proper governance of the agency. An action plan has been completed in relation to public procurement, which will be formally adopted by the management board at its next meeting, which is to be held in June. Furthermore, April 2012 saw the adoption of a new revision of the policy on managing conflicts of interest among members of its scientific and expert committees, alongside a disciplinary procedure for the abuse of trust by members of committees and experts. It will be important to take care over monitoring the implementation and actual results of the new agency management, which deserves all our support and confidence as they continue the renewal and recovery work that the agency needs."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples